Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 10, 2013, Pages 2157-2164

  Zhang, Chunhua ^a   Jin, Ke ^a   Xiao, Yanling ^b   Cheng, Ying ^c   Huang, Zuhu ^a   Wang, Shixia ^a,d   Lu, Shan ^a,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Haiyuan Protein Biotech Co Ltd   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

C. diff toxin; DNA immunization; Immunoglobulin genes; Monoclonal antibody; Toxin A

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; DNA VACCINE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOGLOBULIN GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; TOXIN ANALYSIS;

C. DIFFTOXIN; DNA IMMUNIZATION; IMMUNOGLOBULIN GENES; MONOCLONAL ANTIBODY; TOXIN A;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; ENTEROTOXINS; IMMUNIZATION; MICE, INBRED BALB C; VACCINES, DNA;

EID: 84885168530     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25656     Document Type: Article

References (29)

1. Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011;239:62-84; PMID:21198665; http://dx.doi. Org/10.1111Zj.1600-06 5X.2010.00980.x
2. Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet 2008;9:776-88; PMID: 18781156; http://dx.doi.org/l 0.1038/nrg2432
3. Wang S, Parker C, Taaffe J, Solorzano A, Garcfa-Sastre A, Lu S. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against HI or H3 serotype influenza viruses. Vaccine 2008;26:3626-33; PMID: 18538900; http:ZZdx.doi.orgZl0.1016Zj.vaccine.2008.04.073
4. Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, et al.; VRC 306 Study Team. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis 2011;11:916-24; PMID:21975270; http:ZZ dx.doi.orgZl 0.1016ZS1473-3099 (11) 70240-7
5. Harari A, Bart PA, Stohr W, Tapia G, Garcia M, Medjitna-Rais E, et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 2008;205:63-77; PMID:18195071; http:ZZ dx.doi.orgZl0.1084Zjem.20071331
6. Yan J, Corbitt N, Pankhong P, Shin T, Khan A, Sardesai NY, et al. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine. Vaccine 2011;29:7173-81; PMID:21651948; http:ZZdx.doi.orgZl0.1016Zj.vaccine.2011.05.076
7. Pillet S, Kobasa D, Meunier I, Gray M, Laddy D, Weiner DB, et al. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Vaccine 2011;29:6793-801; PMID:21211587; http:ZZdx.doi.orgZl 0.1016Zj.vaccine. 2010.12.059
8. Vaine M, Wang S, Crooks ET, Jiang P, Montefiori DC, Binley J, et al. Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gpl20 DNA prime-protein boost vaccination compared to gpl20 protein-only vaccination. J Virol 2008;82:7369-78; PMID: 18495775; http:ZZdx.doi.orgZl0.1128ZJVI.00562-08
9. Vaine M, Wang S, Hackett A, Arthos J, Lu S. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. Vaccine 2010;28:2999-3007; PMID:20170767; http:ZZdx.doi.orgZl0.1016/j. vaccine.2010.02.006
10. Wang S, Chou TH, Sakhatskyy PV, Huang S, Lawrence JM, Cao H, et al. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J Virol 2005;79:1906-10; PMID:15650214; http:ZZdx.doi.orgZl0.1128Z JVI.79.3.1906-1910.2005
11. Wang S, Taaffe J, Parker C, Solorzano A, Cao H, Garcfa-Sastre A, et al. Hemagglutinin (HA) proteins from HI and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 2006;80:11628-37; PMID:16987975; http:ZZdx.doi.orgZ10.1128ZJVI.01065-06
12. Barry MA, Barry ME, Johnston SA. Production of monoclonal antibodies by genetic immunization. Biotechniques 1994;16:616-8, 620; PMID:8024780
13. Al-Qaoud KM, Al-Omari MM, Al-Aghbar M, Abdel-Hafez SK. Production of monoclonal antibodies against the 8 kDa subunit of Echinococcus granulosus Antigen B (EgAgB8Z2) using DNA immunization. Hybridoma (Larchmt) 2008;27:431-8; PMID: 18803505; http:ZZ dx.doi.orgZl 0.1089Zhyb.2008.0039
14. Martfn-Folgar R, Lorenzo G, Boshra H, Iglesias J, Mateos F, Borrego B, et al. Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization. MAbs 2010;2:275-84; PMID:20400862; http://dx.doi.org/10.4l61/mabs.2.3.11676
15. Jin K, Wang S, Zhang C, Xiao Y, Lu S, Huang Z. Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B. Hum Vaccin Immunother 2013;9:63-73; PMID:23143772; http://dx.doi.org/10.4l61/hv. 22434
16. Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. J Biomed Res 2010;24:411-6; PMID:23554657; http://dx.doi.org/10.1016/S1674-8301 (10) 60055-3
17. Wei J, Yan B, Chen Z, Li T, Deng F, Wang H, et al. Production and characterization of monoclonal antibodies against the hemagglutinin of H5N1 and antigenic investigation of avian influenza H5N1 viruses isolated from China. Can J Microbiol 2011;57:42-8; PMID:21217796; http://dx.doi.org/l0.1139/W10-097
18. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-Hl anti-hemagglutinin monoclonal antibody with potent broadspectrum efficacy in vivo. J Virol 2012;86:6179-88; PMID:22491456; http://dx.doi.org/10.1128/JVL 00469-12
19. Ulivieri C, Burroni D, Telford JL, Baldari CT. Generation of a monoclonal antibody to a defined portion of the Helicobacter pylori vacuolating cy to toxin by DNA immunization. J Biotechnol 1996;51:191-4; PMID=8987885; http://dx.doi.org/10.1016/0168-1656 (96) 01610-0
20. Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, et al. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods 2003;109:55-61; PMID: 12668268; http://dx.doi.org/10.1016/S0166-0934 (03) 00045-4
21. Horimoto T, Fukuda N, Iwatsuki-Horimoto K, Guan Y, Lim W, Peiris M, et al. Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J Vet Med Sci 2004;66:303-5; PMID: 15107562; http://dx.doi.org/10. 1292/jvms.66.303
22. Wang S, Zhang C, Zhang L, Li J, Huang Z, Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008;26:2100-10; PMID: 18378365; http://dx.doi.org/10.1016Zj.vaccine.2008.02.033
23. Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. J Biomed Res 2010;24:411-6; PMID:23554657; http://dx.doi.org/10.1016/S1674-8301 (10) 60055-3
24. Ryder AB, Huang Y, Li H, Zheng M, Wang X, Stratton CW, et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol 2010;48:4129-34; PMID:20720023; http://dx.doi.org/10.1128/JCM.01104-10
25. Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009;4:372-84; PMID: 19247287; http://dx.doi.org/10.1038/ nprot.2009.3
26. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008;453:667-71; PMID:18449194; http://dx.doi.org/10.103 8/nature06890
27. Liao HX, Levesque MC, Nagel A, Dixon A, Zhang R, Walter E, et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 2009;158:171-9; PMID:19428587; http://dx.doi.org/10.1016/j.jviromet.2009.02.0l4
28. Lightwood DJ, Carrington B, Henry AJ, McKnight AJ, Crook K, Cromie K, et al. Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells. J Immunol Methods 2006;316:133-43; PMID: 17027850; http://dx.doi.org/10. 1016/j.jim.2006.08.010
29. Cline J, Braman JC, Hogrefe HH. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res 1996;24:3546-51; PMID:8836181; http://dx.doi.org/10.1093/nar/24.18.3546